Tokyo, Dec. 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060144) titled 'A prospective study on diagnosis of early chronic pancreatitis by endoscopic ultrasound' on Dec. 22.
Study Type:
Observational
Primary Sponsor:
Institute - Shimane University
Condition:
Condition - acute pancreatitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the effect of activation of protease-activated receptors by pancreatic escape enzymes on the severity of acute pancreatitis.
Basic objectives2 - Bio-equivalence
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1) Patients diagnosed with acute pancreatitis and hospitalized for treatment, or patients diagnosed with abdominal inflammatory diseases other than pancreaticobiliary disease and hospitalized for treatment.
2) Patients who have provided written consent for participation in this study from themselves or their legal representatives.
3) Patients aged 18 years or older.
Key exclusion criteria - 1) Patients with disseminated intravascular coagulation due to malignant disease
Target Size - 30
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 12 Month 20 Day
Anticipated trial start date - 2025 Year 12 Month 22 Day
Last follow-up date - 2028 Year 10 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068790
Disclaimer: Curated by HT Syndication.
